Data / Form D filings / SOLX INC
SOLX INC: Form D filings
SOLX INC, a biotechnology company in Waltham, MA, filed 4 Form D notices with the SEC between 2010 and 2015. The latest, on September 11, 2015, reports $2.3 million sold of a $11 million offering to 5 investors.
Find out what SOLX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 230 SECOND AVENUE, SUITE 120, Waltham, MA, 02451
- Phone
- (781) 609-2016
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1118997
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 11, 2015 | New notice | $10,999,063 | $2,250,000 | $8,749,063 | 5 | Aug 27, 2015 | sec.gov |
| Dec 19, 2013 | New notice | $4,824,000 | $2,124,000 | $2,700,000 | 3 | Dec 11, 2013 | sec.gov |
| Jan 19, 2012 | New notice | $9,000,000 | $3,250,000 | $5,750,000 | 3 | Jan 6, 2012 | sec.gov |
| Oct 27, 2010 | New notice | $7,200,000 | $3,700,000 | $3,500,000 | 6 | Oct 14, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jim Largent | Director | |
| Bosun Hau | Director | |
| Frank Flautt | Director | |
| Eric Bednarski | Director | |
| Kevin McMahon | Executive Officer, Director | |
| Neil Akhurst | Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
Every Form D from the week of Sep 7, 2015 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SOLX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.